StocksMedium•28 October 2026•
1 min read
LENZ Therapeutics Reports 50% Sales Growth and CEO Departure
Key Facts
1LENZ Therapeutics reported a 50% growth in Q3 sales.
2The company announced the upcoming departure of its Chief Executive Officer.
LENZ Therapeutics reported a 50% growth in third-quarter sales. Investing.com reported that the company also announced the upcoming departure of its current Chief Executive Officer from the position.
LENZ closed at $3.15 on October 27, 2026, with the stock trading between a low of $3.08 and a high of $3.19 during that session. This financial performance coincides with a period of leadership transition for the company.